Algazy K - Search Results

1

Phase I trial of the antifolate ZD9331 in combination with cisplatin in patients with refractory solid malignancies.

Bilenker JH, Stevenson JP, Flaherty KT, Algazy K, McLaughlin K, Haller DG, Giantonio BJ, Koehler M, Garcia-Vargas JE, O'Dwyer PJ. Bilenker JH, et al. Among authors: algazy k. Cancer Chemother Pharmacol. 2004 Apr;53(4):357-60. doi: 10.1007/s00280-003-0735-4. Epub 2004 Jan 13. Cancer Chemother Pharmacol. 2004. PMID: 14722734 Clinical Trial.

2

Dose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancer.

Flaherty KT, Stevenson JP, Gallagher M, Giantonio B, Algazy KM, Sun W, Haller DG, O'Dwyer PJ. Flaherty KT, et al. Cancer. 2003 Apr 15;97(8):1985-90. doi: 10.1002/cncr.11273. Cancer. 2003. PMID: 12673728 Free article. Clinical Trial.

3

A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabine.

Flaherty KT, Stevenson JP, Redlinger M, Algazy KM, Giatonio B, O'Dwyer PJ. Flaherty KT, et al. Among authors: algazy km. Cancer Chemother Pharmacol. 2004 May;53(5):404-8. doi: 10.1007/s00280-003-0754-1. Cancer Chemother Pharmacol. 2004. PMID: 15129676 Clinical Trial.

4

Phase I and pharmacokinetic trial of the proapoptotic sulindac analog CP-461 in patients with advanced cancer.

Sun W, Stevenson JP, Gallo JM, Redlinger M, Haller D, Algazy K, Giantonio B, Alila H, O'Dwyer PJ. Sun W, et al. Among authors: algazy k. Clin Cancer Res. 2002 Oct;8(10):3100-4. Clin Cancer Res. 2002. PMID: 12374677 Clinical Trial.

5

A phase I trial of topotecan and gemcitabine administered weekly for 3 consecutive weeks to patients with advanced tumors.

Sun W, Stevenson JP, Gallagher M, Giantonio B, Algazy K, Haller D, Vaughn D, Raskay BJ, O'Dwyer PJ. Sun W, et al. Among authors: algazy k. Cancer. 2001 Jul 15;92(2):414-9. doi: 10.1002/1097-0142(20010715)92:2<414::aid-cncr1337>3.0.co;2-w. Cancer. 2001. PMID: 11466697 Clinical Trial.

6

Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancer.

Stevenson JP, Redlinger M, Kluijtmans LA, Sun W, Algazy K, Giantonio B, Haller DG, Hardy C, Whitehead AS, O'Dwyer PJ. Stevenson JP, et al. Among authors: algazy k. J Clin Oncol. 2001 Oct 15;19(20):4081-7. doi: 10.1200/JCO.2001.19.20.4081. J Clin Oncol. 2001. PMID: 11600611 Clinical Trial.

7

Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancer.

Veronese ML, Stevenson JP, Sun W, Redlinger M, Algazy K, Giantonio B, Hahn S, Vaughn D, Thorn C, Whitehead AS, Haller DG, O'Dwyer PJ. Veronese ML, et al. Among authors: algazy k. Eur J Cancer. 2004 Mar;40(4):508-14. doi: 10.1016/j.ejca.2003.10.022. Eur J Cancer. 2004. PMID: 14962716 Clinical Trial.

8

Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma.

Rangwala R, Chang YC, Hu J, Algazy KM, Evans TL, Fecher LA, Schuchter LM, Torigian DA, Panosian JT, Troxel AB, Tan KS, Heitjan DF, DeMichele AM, Vaughn DJ, Redlinger M, Alavi A, Kaiser J, Pontiggia L, Davis LE, O'Dwyer PJ, Amaravadi RK. Rangwala R, et al. Among authors: algazy km. Autophagy. 2014 Aug;10(8):1391-402. doi: 10.4161/auto.29119. Epub 2014 May 20. Autophagy. 2014. PMID: 24991838 Free PMC article. Clinical Trial.

9

Phase I trial of the cryptophycin analogue LY355703 administered as an intravenous infusion on a day 1 and 8 schedule every 21 days.

Stevenson JP, Sun W, Gallagher M, Johnson R, Vaughn D, Schuchter L, Algazy K, Hahn S, Enas N, Ellis D, Thornton D, O'Dwyer PJ. Stevenson JP, et al. Among authors: algazy k. Clin Cancer Res. 2002 Aug;8(8):2524-9. Clin Cancer Res. 2002. PMID: 12171879 Clinical Trial.

10

Gefitinib in patients with advanced non-small cell lung cancer (NSCLC): the expanded access protocol experience at the University of Pennsylvania.

Veronese ML, Algazy K, Bearn L, Eaby B, Alavi J, Evans T, Stevenson JP, Shults J. Veronese ML, et al. Among authors: algazy k. Cancer Invest. 2005;23(4):296-302. doi: 10.1081/cnv-61528. Cancer Invest. 2005. PMID: 16100941 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page